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Abstract
Transgender and gender non-binary (TGNB) individuals face discrimination in healthcare settings and barriers
to healthcare access, resulting in health disparities. These inequities are compounded by the intersection of
lower socioeconomic status and geography. To understand the differences in how states provide healthcare to
TGNB individuals in poverty, we ask: What are state Medicaid programs offering TGNB residents, and how
can coverage be more equitable across jurisdictions? To answer these questions, we examine medical services
covered by 15 diverse Medicaid programs and compare them to the services recommended by the World
Professional Association for Transgender Health (WPATH). Unsurprisingly, the analysis reveals inconsistent
TGNB health coverage across states. While some states include coverage for TGNB-related care, some do not,
and others place access to services in the hands of medical providers. These coverage disparities leave many
TGNB Medicaid recipients across the U.S. without coverage for medically necessary services, prompting equity
questions for both research and practice.

Key Words: Healthcare; Medicaid coverage; Transgender and Gender Nonbinary (TGNB)
Points for Practitioners:
•
•
•

Recognized standards of care for transgender and gender non-binary (TGNB) people have been established
by the World Professional Association for Transgender Health (WPATH)
TGNB health care needs are not limited to gender confirming surgeries.
Medicaid programs may not provide access to the full spectrum of health care services required by
Medicaid-eligible TGNB individuals, which should be rectified. Alternatively programs may establish
barriers to access, such as prior authorization requirements, which should be eliminated.

Beginning in the early 2000s, transgender1 and gender non-binary2 (TGNB) people have
experienced greater visibility in many aspects of life in the United States. Alongside their
lesbian, gay, and bisexual counterparts, TGNB Americans have lobbied, and continue to
lobby, for policy that supports their full inclusion in various facets of society, with healthcare
being a key area. Some federal and state policymakers and public administrators have
attempted to address the needs of this community, but despite modest gains, and amidst the
backlash by counter-TGNB movements, stigma persists. TGNB people continue to be
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marginalized, especially when seeking health services specific to their gender experience (see,
e.g., Poteata, German & Kerrigan 2013; JSI Research and Training Institute Inc. 2000;
Franzini & Casinelli 1986; Green, Stoller, & MacAndrew 1966).
One example of TGNB marginalization is when a healthcare plan fails to provide
coverage for standard TGNB services. A second example is considering gender-affirming
surgeries, i.e., chest and genital surgeries, as the only standard service necessary for TGNB
individuals. This research explores the extent to which state Medicaid programs cover the full
range of services to TGNB residents, beyond gender-affirming surgeries, to help determine
how these coverage options could be improved across jurisdictions. We find that the
Medicaid programs examined here take inconsistent approaches when it comes to covering
the wide spectrum of TGNB-related services. While some states include coverage for TGNBrelated care, some do not, and some put this coverage determination in the hands of medical
providers. This unequitable approach leaves many TGNB Medicaid recipients without
coverage for medically-necessary services. These findings lead to recommendations for policy
makers and administrators seeking to build equity for vulnerable TGNB residents within their
states’ Medicaid programs.
Understanding TGNB Discrimination Generally and in Healthcare: Erasure and Hypervisibility
Historically, discrimination against the TGNB population in public administration settings
has generally taken the form of “erasure” or “hypervisibility.” Erasure is a “nullification of
transgenderism through a binary discourse” (LeBreton 2013, citing Lombardi 2001). In other
words, policies or speech recognize only two genders, male and female, which results in the
TGNB individuals’ existence being “erased.” Although the erasure of TGNB people from
public administration settings can occur for many reasons (Namaste, 2000; Stryker, 2008),
most scholars suggest the reason is “cisnormativity,” i.e., the assumption that human beings
are either male or female and that a person’s gender is consistent with the gender assigned
at birth (Bauer et al, 2009; LeBreton, 2013; Collier & Daniel, 2019). Cisnormativity creates
both institutional erasure for TGNB people in the form of silence in policies, forms, and
infrastructure, resulting in such institutions ignoring TGNB needs; and informational erasure
via a lack of research, training, and availability of information for leaders and policymakers,
resulting in little reliable information about TGNB needs and a narrow distribution of any
legitimate information (Bauer et. al, 2009). An example of erasure in a healthcare plan could
be the failure to provide coverage for needed TGNB services.
Yet, the cisnormative public space does more than simply erase TGNB people
1

Defined as: “An umbrella term for people whose gender identity and/or expression is different from cultural
expectations based on the sex they were assigned at birth. Being transgender does not imply any specific sexual orientation. Therefore, transgender people may identify as straight, gay, lesbian, bisexual, etc.” (Human
Rights Campaign 2020).
2

Defined as: “an adjective describing a person who does not identify exclusively as a man or a woman. Nonbinary people may identify as being both a man and a woman, somewhere in between, or as falling completely
outside these categories. While many also identify as transgender, not all non-binary people do” (Human
Rights Campaign 2020).
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(Namaste, 2000); it also isolates them, producing what Collier and Daniel (2019) term
“hypervisibility” (p. 2). Hypervisibility, like erasure, is mistreatment based on identity, but
rather than ignoring or overlooking a person’s existence and needs, hypervisibility places an
intense focus on a person so as to mark them as deviant (Buchanan and Settles 2018). Some
scholars point to the source of hyper-visualization of the TGNB population to their
pathologization in the medical literature of the middle 19th and early 20th centuries (Stryker,
2008; Levi & Barry, 2019; Stroumsa, 2014). As a result of hypervisibility, TGNB people
become one-dimensional stereotypes. An example of hypervisibility in a healthcare plan could
be solely providing coverage for sex-affirming surgeries and failing to make available the
range of services that TGNB people typically need because of this singular focus.
Erasure coupled with hypervisibility makes TGNB individuals more vulnerable to
abuse, both physically and administratively, in a system that simultaneously excludes them
while it separates them out as the “other.” In the healthcare setting, TGNB erasure and
hypervisibility result in individuals facing numerous barriers and discriminatory practices
(Sperber et al, 2005; Stroumsa, 2014; James et al, 2016; Rodriguez et al, 2018). On one
hand, erasure occurs when healthcare providers lack the competency, and even the
willingness, to treat TGNB patients (Sperber et al, 2005; Shires et al, 2018) or where a
health plan fails to provide coverage for the range of services needed. Hypervisibility occurs
when providers continue to over emphasize the gender identity of TGNB individuals when
making diagnoses (Sperber et al, 2005; Bauer et al, 2009) or when a health plan only
provides coverage gender-affirming surgeries. TGNB individuals also face verbal and physical
harassment within medical settings (James et al, 2016; Rodriguez et al, 2018). This
phenomenon is exacerbated for those whose physical presentation is non-binary (Stroumsa,
2014).
Today, the understanding that TGNB lives should be conceptualized only through
medical and psychiatric research has abated. Rather, scholars have begun to additionally
consider the settings in which TGNB individuals live and work (Namaste, 2002, p. 53). In
these settings - health, education, housing, employment, etc. - erasure and hypervisibility
produces numerous obstacles to TGNB access (James, et al, 2016). It is within this larger,
systemic erasure and hypervisibility in the current U.S. context (Namaste, 2000; Stryker,
2008; Bauer et al, 2009; LeBreton 2013, Collier and Daniel, 2019) that we explore what
state Medicaid programs offer TGNB residents and how coverage can be more equitable
across jurisdictions.
Access to healthcare services is an important issue to study because health disparities
in the TGNB population, in particular mental health disparities, have been documented
(Sperber et al, 2005; Poteat et al, 2013). For example, it has been shown that TGNB
individuals suffer higher rates of suicide, depression, hospitalization, HIV infection, and
mental health morbidity, among others (Sperber et al, 2005; Bauer et al, 2009; LeBreton,
2013; Poteat et al, 2013; Stroumsa, 2014; James et al, 2016; Progovac et al, 2018).
Although scholars have not yet made an explicit connection between these disparities and the
systemic dynamic of erasure and hypervisibility of TGNB individuals in healthcare, and we do
not attempt to do that here, it is not incredible to imagine the connection when considering
research focused on the health disparities in the Black American community. Clark, et al.
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(1999) identified the link between systemic racism and poor health outcomes, which has led
to further research on the ways in which Black Americans perceive racism in healthcare.
TGNB individuals, like Black Americans, face erasure in medical literature, training, and
policies. Also, TGNB individuals, like many Black Americans, are recognizable as such within
provider settings (Rodriguez et al, 2018), which fact lends itself to hypervisibility in
treatment. Thus, it is likely that both systemic erasure and hypervisibility have contributed
to TGNB health disparities in the same way as they have for Black Americans.
In the discipline of public administration, there has been limited research conducted
pertaining to the erasure and hypervisibility of TGNB individuals in healthcare
administration. Broadly, public administration scholarship centers around the accommodation
of the “other” (Namaste, 2000) and focuses on the need for greater cultural competency
among public managers (Blessett et al, 2016; Carrizales et al, 2016; Rollins & Grooms,
2019). A more effective and efficient public service is said to occur when there is a greater
awareness of the needs of individuals marginalized due to their gender, race, ability, sexual
orientation, and language in public settings (Carrizales et al, 2016). Further, public managers
should be aware of the phenomenon of “intersectionality” (Crenshaw 1989), where
overlapping experiences of discrimination and marginalization due to an individual falling into
multiple categories of identity complicates an individual’s needs.
In addition to the cultural competency literature, other studies relevant to the TGNB
experience are more narrow in scope, focusing specifically the ways in which TGNB
individuals are impacted by discrimination in shared public spaces. Examples of these public
spaces include bathrooms (Herman 2013), the immigration system (Collier & Daniel, 2019),
local government (Elias 2020), and federal employment (Elias, 2017/2018). The present
research advances public administration scholarship by focusing on the intersection of
cultural competence and policy in the provision of healthcare to the TGNB population
through Medicaid, the joint federal and state program that provides access to healthcare for
individuals in poverty.
TGNB Healthcare Needs and Medicaid Policy
For this research, Medicaid must be distinguished from Medicare, a federal program that
provides health care coverage to the elderly, i.e., people sixty-five and older, and disabled
individuals. There are no income requirements needed for someone to become eligible for
Medicare. On the other hand, Medicaid, which is administered on the state level but funded
from both federal and state sources, requires beneficiaries to prove that their income is at or
below state-established thresholds. The level of poverty required for eligibility for Medicaid
varies from state to state. By examining Medicaid healthcare provision to TGNB individuals
in a sample of U.S.states, we are able to examine what happens to people dealing with
intersectionality of non-cisnormative gender, socioeconomic status, and geography. This
intersectionality is important as TGNB discrimination has been shown to be compounded not
only by the intersectionality of race (Brown & Jones 2014) and sexual orientation (Mizock &
Hopwood 2016), but also socioeconomic status (Budge et al 2016) and geography (White
Hughto, et al. 2016).
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Medicaid programs are also an important area of study as legal and policy scholars
call attention to the dichotomy that currently exists between the tone of medical research
and federal policy (Stroumsa, 2014; Rosh, 2017; Grieser, 2018; Waller, 2018; Levi and Barry,
2019; Baker, 2019). The American Medical Association, American Psychological Association,
and American Psychiatry Association have long arrived at a consensus that sex assigned at
birth3 and gender identity4 are distinct entities which, when out of alignment, may cause
gender dysphoria5 (American Medical Association 2018; American Psychological Association
2015; American Psychiatry Association 2017). Since gender dysphoria is a condition listed in
the Diagnostic and Statistical Manual of Mental Disorders (DSM) (American Psychiatric
Association 2013), there is also considerable medical consensus concerning its treatment
protocols that neither erase or make hypervisible a TGNB individual. For instance, the World
Professional Association for Transgender Health (WPATH) first published its Standards of
Care for the Health of Transexual, Transgender, and Gender Non-Conforming People (SOC)
in 1980, and in 2012, put out its seventh version. The SOC dispel the misconception that all
TGNB people seek gender confirming surgery by highlighting the importance of a range of
different services that, for some TGNB people, could be enough to ameliorate their gender
dysphoria (WPATH, 2012, p. 8). As there are no standard-setting bodies with statutory
authority over the provision of medical care in the U.S., the WPATH SOC have become
recognized as important standards that should guide U.S. physical and behavioral health
practitioners in their TGNB care provision.
In addition to the setting of SOC by international healthcare researchers, federal
health policy had been gradually shifting from erasure to inclusivity for TGNB people.
Specifically, in 1999, the American Public Health Association (APHA) issued a policy
statement that called upon the Centers for Disease Control and Prevention and the National
Institutes of Health to address TGNB erasure by “mak[ing] available resources, including
funding for research, that will enable a better understanding of the health risks of
transgendered individuals, especially the barriers they experience within healthcare
settings” (APHA, 1999). Subsequently, the National Institute of Minority Health and Health
Disparities (NIMHD) officially recognized TGNB people as a “health disparity population,”
reaffirming APHA’s call for research funding (NIMHD, 2016). The availability of funding led
to further research in the U.S. about the health of TGNB citizens.
Additional gains occurred with the passage of the Patient Protection and Affordable
Care Act (ACA) in 2010. Section 1557 of the ACA included a sex-based non-discrimination
mandate. While working to implement the ACA, the Department of Health and Human
Services (HHS) under President Barack Obama pledged to ensure TGNB individuals received
the benefit of the non-discrimination protections contained within Section 1557. Regulatory
documents stated clearly: “Discrimination on the basis of sex . . . includes discrimination on
3

Defined as “the sex (male or female) given to a child at birth, most often based on the child's external anatomy” (Human Rights Campaign 2020).
4
Defined as “one’s innermost concept of self as male, female, a blend of both or neither – how individuals
perceive themselves and what they call themselves. One's gender identity can be the same or different from
their sex assigned at birth” (Human Rights Campaign 2020).
5
Defined as “a conflict between a person's physical or assigned gender and the gender with which he/she/they
identify, . . . a condition marked by such distress” (Parekh, 2016).
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the basis of gender identity” (HHS, 2016).
Nevertheless, in recent years, since 2016, federal policy has appeared to reverse itself.
For instance, the Department of Health and Human Services (HHS) under President Donald
Trump took steps to erase TGNB people from federal health programs through new
interpretations of Section 1557 of the ACA. (Stroumsa, 2014; Rosh, 2017; Grieser, 2018;
Waller, 2018; Levi & Barry, 2019; Baker, 2019). Specifically, HHS announced their intention
to reinterpret the provision to more narrowly define sex. In addition, HHS stopped enforcing
Section 1557 in the wake of a federal court case that concluded that the gender identity
protections of Section 1557 violated medical providers' religious freedom (Franciscan Alliance
v. Azar, 2019)6.
Further compounding this confusion about TGNB health coverage is the 2016
decision by the Centers for Medicare and Medicaid Services (CMS) to decline to provide
nationwide coverage of gender-affirming surgeries in the Medicare program, claiming there
was insufficient clinical evidence to support a medical need for these surgeries for the elder
TGNB population (CMS 2016). Thus, Medicare coverage was left to be determined on a
case-by-case basis. Although Medicare and Medicaid are very different programs, the lack of
clear federal guidance around TGNB healthcare in the Medicare program and the shifting
understanding of anti-discrimination provisions of ACA results in Medicaid health programs
becoming gatekeepers for providing, or denying, TGNB-affirming health coverage to
Medicaid eligible beneficiaries (Spade, 2010). The legal purgatory allows for states to
specifically exclude coverage of certain TGNB healthcare services (Rosh, 2017).
This project seeks to move beyond the typical approach examining TGNB-related
healthcare coverage that focuses solely on gender-affirming surgeries. By assessing a sample
of state Medicaid programs to determine the extent to which the full range of service
identified in the WPATH SOC, this work will fill a needed gap in the TGNB health policy
scholarship. Identifying gaps between Medicaid coverage and the most current TGNB SOC
helps demonstrate how states can make amendments to promote a more equitable public
healthcare system. Some research has already shown, coverage for TGNB-related services is
cost effective relative to the systemic cost of continued health disparities and poor outcomes
(Padula, 2016; Baker, 2019). Yet, no research has assessed current offerings in Medicaid in
order to offer a blueprint for that coverage.
Methodology
This research builds on preliminary research on the variation in TGNB health coverage across
state Medicaid programs completed by the Movement Advancement Project (MAP), a
nonprofit think tank promoting equality for all. MAP has been tracking lesbian, gay,
bisexual, and transgender (LGBT) equality along various axes in all 50 states for some time;
however, their study of Medicaid coverage is limited because it only examines a state’s
6. The administration of President Joe Biden has issued an executive order to prevent and combat discrimination on the basis of gender identity and sexual orientation (Exec. Order No. 13,988, 2021), which will
hopefully reverse these punitive actions of the Trump administration.
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Medicaid program to determine whether it includes, excludes or is silent on the coverage of
gender-affirming surgeries (MAP 2020).7 The categorization of states as either “including,”
“excluding,” or “silent” unintentionally emphasizes both hypervisibility and erasure of the
TGNB population. First, hypervisibility occurs because MAP’s research focuses solely on
gender-affirming surgeries, ignoring the broad spectrum of care suggested for TGNB patients’
experience of dysphoria under WPATH standards. This emphasis has the effect of reducing
TGNB patients to uni-dimensional stereotypes of surgery-seeking individuals. Second, MAP’s
research suggests that erasure is occurring in the states with Medicaid programs that are
silent on the issue of gender-affirming surgeries. Yet, this conclusion is too simplistic as it
likewise fails to consider the WPATH SOC. Identifying which states provide (or don’t
provide) the entire range of care for TGNB beneficiaries provides a more complete picture of
the care offered to low income TGNB individuals and identifies where there are holes in
coverage.
To understand the landscape of TGNB healthcare coverage in state Medicaid
programs, we conducted a directed content analysis (Hsieh and Shannon 2005) of state
Medicaid program provisions to determine the extent to which each state covers the range of
medically necessary services listed under the WPATH SOC for TGNB Medicaid beneficiaries.
An analysis of all 50 states was not feasible or practical for an in depth review of Medicaid
policies, so we decided to pursue a purposive sample of states with a wide variety of
characteristics that might help explain to extent to which state Medicaid plans covered the
full range of recommended TGNB healthcare services. The first element of variation was
based on the three categories used by MAP: including, excluding, or neither including or
excluding gender-affirming surgeries. For the purposes of this study, the three categories are
referred to as including, excluding or neither, respectively.8 The goal of this purposive
sampling was to use MAP’s labels as the initial criterion of variation among the states in the
sample.
To increase variation among the sampled states, we compiled a table of additional
state indicators that would signal Medicaid policy variation among states. These included:
total Medicaid spending in fiscal year 2018; population size in 2018; calculated Medicaid
spending per capita; percentage of the population living in poverty in 2018; the annual
number of medical school graduates in 2018; whether the state chose to expand Medicaid
under the ACA (Yes or No); and the majority party in the 2016 presidential election
(Republican or Democrat). We also considered indicators that would signal the likelihood
that a state would be more or less friendly to its TGNB residents, because research has
uncovered regional variation in descrimination against the LBGT population (Swan 2014)
and has found a correlation between transgender-inclusive state policies and improved health
coutcomes (Dubois, et al. 2018). These included: Medicaid coverage for abortion (Yes or
No); the availability for a third gender option on state identifications (Yes or No); a ban on
conversion therapy (Yes or No); and the legality of the “gay panic” defense, a defense raised
7

MAP uses the term “transition-related care,” but this term is used only to refer to coverage for surgeries that
affirm gender.
8
As of October 2019, when this study was conducted, MAP had classified 19 states (and D.C.) as including,
7 as excluding, and 24 states as neither (MAP, 2020).
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in criminal trials that suggests the defendent was in part reacting to the gender or sexual
orientation of the victim (Yes or No). Appendix A provides a table of these indicators across
all 50 states. Within each MAP category - including, excluding, and neither - we selected five
states that demonstrated variation along multiple indicators. The following table lists the
states selected for the sample.
Table 1. States Selected for the Present Study
Medicaid Programs Explicitly
Include Coverage for GenderAffirming Surgery

Medicaid Programs Explicitly
Exclude Coverage for GenderAffirming Surgery

Medicaid Programs are Neither
Exclude or Include Coverage for
Gender-Affirming Surgery

California

Alaska

Florida

Illinois

Missouri

Idaho

Michigan

Ohio

Maine9

New York

Tennessee

Mississippi

Pennsylvania

Wyoming

New Mexico

Source: MAP (2020).

In order to determine whether the full range of TGNB care is covered within our
sample states’ Medicaid programs, it was first necessary to establish the codes to be used,
based on the types of services WPATH recommends. There are approximately 5010 services
and 9 medications contained within the SOC; however, for ease of analysis, we grouped
services into 4 categories: mental healthcare, hormone therapy, surgery, and other. Services
in the mental healthcare category include both psychiatry and psychotherapy assessments
and ongoing treatment. Hormone therapy includes the office visit with a primary care
physician (PCP) to assess the need for hormone therapy, labs, and any medications taken for
the purposes of feminization or masculinization. The surgery category is by far the most
expansive, and includes common procedures - hysterectomies, breast augmentation - and
niche procedures like clitoroplasties or testicular implants. Preventative services such as
mammograms, sexual health testing, and TB screens are part of the other category along
with cryopreservation, and voice/communication therapy. Table 2 provides the full list of
SOC broken down into the four categories.
Using the predetermined codes based on the WPATH SOC, we coded the regulatory
documents for each of the states in the sample that codified Medicaid coverage decisions.
These regulatory documents varied from state to state and included state administrative
codes, provider manuals, bulletins, pharmacy manuals, and program handbooks.11 For each
state, we determined whether the services were covered, marking a “yes” or a “no” on the
data collection document. In some cases, we noted that a service might be potentially
9

Since the time of this research, Maine has explicitly included coverage for TGNB services in its state Medicaid policy (MAP, 2019).
10
Common preventive services recommended by WPATH, e.g., colonoscopy, PAP, etc., are grouped into one
type of service for this analysis. Likewise, various aesthetic surgeries are also grouped into one type of service.
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covered by a state when the state required the patient to obtain prior authorization or show
an additional qualifying condition.
Table 2. Categories of Recommended TGNB Services by WPATH SOC
Mental Healthcare

Hormone Therapy

Surgery

Other

Psychosocial evalua- Office visit- primary care Breast/Chest Surgery for
Cryopreservation
tion/ assessment
physician
individuals assigned male at
birth including: augmentation
mammoplasty
Ongoing
psychotherapy

Labs

Breast/chest surgeries for
Voice and
individuals assignment female communication
at birth, including:
therapy
mastectomy, and male chest
contouring

Family therapy

Medications for individuals Genital surgeries for
Preventative services
assigned male at birth,
individuals assigned male at
including: Injectable and birth, including: penectomy;
transdermal estrogen;
orchiectomy; vaginoplasty;
anti-androgen; and
clitoroplasty; and vulvoplasty
progestin

Treat/ prescribe for Medications for
Genital surgeries for
underlying
individuals assigned female individuals assigned female at
conditions
at birth, including:
birth, including: hysterectomy;
injectable, transdermal andsalpingo-oophorectomy;
implantable testosterone ; metoidioplasty; phalloplasty;
and compounded
urethra reconstruction;
hormones
vaginectomy; scrotoplasty;
testicular prosthesis; and
implant of erection
Referrals

Non-genital/breast surgeries
for individuals assigned male
at birth, including: facial
feminization surgery;
liposuction; lipofilling; voice
surgery; thyroid cartilage
reduction; gluteal
augmentation; hair
reconstruction; and other
aesthetic surgeries

Source: WPATH (2012).

Results
Our analysis shows that the states in our sample provide a wide variety of TGNB health
coverage to TGNB Medicaid beneficiaries. Generally, states that were labeled as adopting a
hypervisable approach to providing healthcare to TGNB Medicaid beneficiaries (either
11

Only fee-for-service (FFS) Medicaid programs were considered for this analysis.
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excluding or including gender-affirming surgeries) followed a similar path of coverage for
other services. In other words, “including” states (California, Illinois, Michigan, New York,
and Pennsylvania) cover more services for TGNB Medicaid beneficiaries, and “excluding”
states (Alaska, Missouri, Ohio, Tennessee, and Wyoming) provide fewer. This is true
regardless of whether the states have large or small Medicaid programs, high or low poverty,
and a Republican or Democratic leaning. In comparison, the “neither” states (Florida, Idaho,
Maine, Mississippi, and New Mexico) provide the most variation on their coverage. Table 3
presents the coverage in each of the 15 states in our sample.
Looking more closely, in states identified as explicitly including gender-affirming
surgery in their Medicaid programs, beneficiaries are covered for nearly all services
recommended by the WPATH, including chest and genital surgeries and all hormonal
delivery methods, although coverage of non-chest/non-genital surgeries varied the most. Of
these five, Illinois blanketly rejects coverage for non-genital/non-chest surgeries for TGNB
individuals, whereas in the other including jurisdictions, these traditionally “cosmetic”
procedures may be covered via prior authorization and/or letter of medical necessity.
Michigan’s program offers its insured the most direct path to these types of surgeries via
simple prior authorization. California, New York, and Pennsylvania programs would likely
cover these procedures but only after a lengthy appeal process following an initial prior
authorization.
In contrast, states identified as explicitly excluding gender-affirming surgery
predictably covered few, if any, non-genital/non-breast surgical services. A Medicaid
beneficiary seeking surgery in any of these any jurisdictions will not receive coverage with the
unique exception of Wyoming, where orchiectomies12, hysterectomies, and salpingooophorectomies13 may be covered with prior authorization. Nevertheless, most hormone
options are covered within these jurisdictions with two exceptions. Alaska has the most
restrictive hormone policies, requiring a patient’s gender marker to correspond with the
prescribed hormone. In other words, estrogen can only be covered if prescribed to a patient
with “F” as a gender marker, and testosterone can only be covered if prescribed to a patient
with “M” as a gender marker. Tennessee takes a similar approach, but only for testosterone.
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Table 3. State’s Coverage of WPATH’s Standards of Care for TGNB Individuals
Including
Mental
Hormone Therapy
Surgery
Other
States

Healthcare
Yes

Yes

Illinois

Yes

Yes

Michigan

Yes

Yes

New York

Yes

Yes

Pennsylvania

Yes

Yes

California

Excluding States
Alaska

Yes

Missouri

No

Ohio

Yes

Yes, although non-genital/
breast surgeries only
covered after an appeals
process

Yes, except voice therapy
requires prior
authorization and
cryopreservation is not
covered
Yes, although non-genital/ Yes, except voice therapy
breast surgeries are not
requires prior
covered
authorization and
cryopreservation is not
covered
Yes, although non-genital/ Yes, except voice therapy
breast surgeries require
requires prior
prior authorization
authorization and
cryopreservation is not
covered
Yes, although non-genital/ Yes, although
breast surgeries only
cryopreservation is not
covered after an appeals
covered
process
Yes, although non-genital/ Only preventative services
breast surgeries only cov- are covered, no cryopresered after an appeals pro- ervation and voice therapy
cess

All testosterone treatNo
ments are limited to
individuals with an “M”
gender marker,
accompanied with prior
authorization. All estrogen
treatments are limited to
individuals with an “F”
gender marker,
accompanied with prior
authorization
Yes, except implantable No
testosterone. Compounded
hormones may not be
covered

Yes, except voice therapy
require may prior
authorization and
cryopreservation is not
covered

Yes, although injectable No
estrogen and injectable
testosterone require prior
authorization. Compounded hormones are covered
if the active ingredient is
also covered.

Yes, except voice therapy
may require prior
authorization and
cryopreservation is not
covered

Only preventative services
are covered, no cryopreservation and voice therapy
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Table 3, continued

Excluding

Mental
Healthcare

Hormone Therapy

Tennessee

Yes, although
family therapy
may not be
covered

Yes, except injectable
No
estrogen and implantable
testosterone; other
testosterone may only be
provided for individuals
with an “M” gender
marker

Only preventative services
are covered, no
cryopreservation and voice
therapy

Wyoming

Yes

Yes, except prior authori- No
zation may be required for
estrogen products and
injectable testosterone.
Implantable testosterone
is not covered.
Compounded hormones
are covered if the active
ingredient is also covered.

Yes, except voice therapy
may require prior
authorization and
cryopreservation is not
covered

Florida

Yes

Yes, except transdermal Yes, with prior
Yes, except voice therapy
testosterone requires a
authorization and proof of is only covered for
prior authorization, and medical necessity
individuals under the age
implantable testosterone
of 21 and cryopreservation
is not covered
is not covered

Idaho

Yes

Only transdermal testos- Yes, with prior
Yes, except voice therapy
terone is covered, along authorization and proof of may require prior
with primary care and lab medical necessity
authorization and
work
cryopreservation is not
covered

Maine

Yes

Yes, except implantable
testosterone

Yes, with prior
Yes, except voice therapy
authorization and proof of may require prior
medical necessity
authorization and
cryopreservation is not
covered

Mississippi

Yes

No, any surgeries related to Only preventative services
a diagnosable mental illness are covered, no cryopresare not covered
ervation and voice therapy

New Mexico

Yes

Only transdermal testosterone is covered along
with primary care and lab
work.
Yes, but only with prior
authorization

States,
continued

Surgery

Other

Neither States

Genital and breast surgery
is covered with prior
authorization and proof of
medical necessity. Nongenital/ breast surgeries
may be covered after
review

Yes, except voice therapy
may require prior
authorization and
cryopreservation is not
covered

Sources: Alaska Department of Health and Social Services (n.d.); California Department of healthcare Services
(2007A, 2007B, 2007C); Florida Agency for Healthcare Administration (2012, 2016, 2020); Idaho Department of
Health & Welfare (1991, n.d.); Illinois Department of Healthcare and Family Services (2014, 2016, 2018); Maine
Department of Health and Human Services (n.d.); Michigan Department of Health and Human Services (2020);
Mississippi Division of Medicaid. (n.d.A, n.d.B, n.d.C, n.d.D); MoHealth.Net (2019A, 2019B, 2019C); New Mexico
Administrative Code (n.d.A, n.d.B); New York State Medicaid Program (2011, 2015); Ohio Department of Medicaid (n.d.A, n.d.B, n.d.C); Pennsylvania Commonwealth Code (n.d.); Tennessee Department of Finance and Administration Bureau of TennCare. (2019, 2020); and Wyoming Department of Health (2019), retrieved 10-2019.
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Results from the third category of states, labeled as silent about gender-affirming
surgery, vary broadly from both each other and the other two groups of states. Though some
states require prior authorization, hormone treatments are covered in all states, with the
notable exception of Idaho, which will only cover transdermal testosterone, i.e., testosterone
delivered by way of a patch placed on the skin. Maine, Idaho, and Florida cover almost all of
the WPATH services with prior authorization and letter of medical necessity from the
medical provider. In New Mexico, coverage for the traditionally “cosmetic” procedures, i.e.,
non-genital/non-breast surgeries, is possible, but may entail a lengthy appeal process similar
to the including states of California, New York, and Pennsylvania. Mississippi, on the other
hand, will not cover any of these surgeries and requires a prior authorization for all hormone
medications, making this state more restrictive than nearly all of the excluding states. This is
accomplished through language in their administrative code, which excludes, “Any operative
procedure, or any portion of a procedure, performed primarily to improve physical
appearance and/or treat a mental condition through change in bodily form" (State of MS,
2014). This provision does not expressly refer to gender-affirming surgery, which is why
Mississippi is labeled neither by MAP; yet since gender dysphoria is listed in the DSM making it a mental condition - this language creates an operational exclusion for TGNB
surgery without actually referring directly to TGNB individuals, a unique approach among
these fifteen states.
Overall, the data show that certain types of services are provided more readily by all
states than others. For example, with the exception of Missouri, an excluding state, all of the
states cover the mental health services that TGNB individuals would need. Additionally, all
states cover primary care physician visits, lab services, and preventative care, such as
colonoscopies, mammograms, and PAP smears. On the other hand, none of the selected
states cover cryopreservation of eggs and sperm for any beneficiary, regardless of a person’s
gender identity.
Whether a state covered voice therapy services was difficult to ascertain in many of
the states. In Alaska, an excluding state, for example, speech therapy is covered “when
medically necessary,” which is generally consistent with WPATH SOC; however, the Alaska
manual goes on to define speech therapy services to include “screening, evaluation, and
treatment of defects and disorders of the voice and spoken/written
communication” (ADHSS, 2019, p. 18). It is unclear whether medical necessity based on the
WPATH SOC would be able to override the second limitation. Similarly, voice therapy
services appear to be potentially covered in eight other states and fully covered in the state
of New York, an including state.
Coverage for hormone medications and surgeries, regardless of type, varied the most.
Outside of the including states, which cover all hormone therapies, most states require prior
authorization, especially for injectable estrogen and injectable testosterone, and gender
markers are used to restrict access. For surgeries, even the including states require prior
authorization for non-gential/breast surgeries. The neither states require prior authorization
12
13

The removal of the testicals
The removal of the ovaries and fallopian tubes
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and a showing of medical necessity for any surgery, except for Mississippi which prohibits all
surgeries recommended by WPATH.
Conclusions, Limitations, Recommendations, and Further Research
There are many reasons to be encouraged by the results of this study from an equity
perspective. In the states we examined, there is near universal access to primary care,
preventative care, and mental health services, the importance of which is emphasized by the
WPATH SOC. The SOC states that “gender identities and expressions are diverse, and
hormones and surgery are just two of many options available to assist people with achieving
comfort with self and identity” (WPATH, 2012, p. 5). Thus, not all TGNB individuals seek
hormonal or surgical treatment, and for some, a trusting relationship with a primary care
physician and/or ongoing mental healthcare could be enough to promote overall health.
The results also reveal that Medicaid programs in the sample that neither include or
exclude coverage for gender-affirming surgery, the neither states, by and large provide
coverage for these services through a prior authorization and/or letter writing process. In
fact, only Mississippi completely bans all surgeries. This means that access to surgeries in
these states are possible. In addition, these processes are utilized in both including and
excluding states. In including states, they are used for non-genital/breast surgeries, and in
excluding states, they are more commonly used for hormone medications.
Lastly, these results identify some exemplary states with policies and practices that
can be modeled. For example, California and Pennsylvania enact very few barriers to care
and cover all WPATH recommended services with the exception of cryopreservation.
Notably, both of these states have issued fomal guidance to Medicaid providers in the
immediate aftermath of the original 2016 HHS non-discrimination enforcement rule. Both
bulletins made direct references to WPATH standards in making statewide coverage
determinations. Pennsylvania’s bulletin advises “In determining medical necessity for gender
transition services, the Department and Managed Care Organizations (MCO’s) will use the
World Professional Association for Transgender Health (WPATH) Standard of Care as
guidelines and any successor WPATH guidelines to determine whether the services are
medically necessary” (PDHS, 2016).
There are also points of caution regarding access to TGNB care. It is clear from this
analysis that there is less coverage for hormone medications and surgeries across the sample
of state Medicaid programs, with no possibility of surgery coverage in over one third of the
selected states. Access to hormone therapy and surgery remains a critical component of
quality TGNB care, and according to the WPATH SOC, are medically necessary treatments
for many cases of gender dysphoria. State health programs remain unchecked by federal
policy in their ability to withhold these elements of care. And although prior authorization
requirements are widely utilized by the Medicaid programs in this study, even in inclusionary
states, these also create potential barriers to care. How medical and mental health providers
and their administrative support teams engage in this process can be the determining factor
in coverage for a particular medication or service. Providers, therefore, possess much of the
power in achieving positive health outcomes with their TGNB patients and can be the only
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factor influencing Medicaid coverage determinations in their jurisdictions. Medical providers
who are not TGNB-competent will likely not effectively navigate complicated approval
processes.
This study provides valuable insights into the ways in which state Medicaid programs
provide coverage for the medical services needed by TGNB residents, but there are
limitations in its research design. We did not examine the Medicaid Programs in all U.S.
states and territories, focusing only on a small subset. Our analysis looked only into services
provided for within FFS Medicaid programs and did not consider Medicaid-managed care
plans. Further, in states that have not expanded Medicaid, large segments of the population
are excluded from coverage. Only children and adolescents, mothers, and the elderly are
typically included in these FFS programs.
Additional research on this topic should expand the sample to include Medicaid
programs nationwide. Consideration could also be given to an analysis of Medicare, the
Veterans Affairs’ programs for active and retired members of the military, and the Indian
Health Service. Additionally, knowledge from the public health community, TGNB health
experts, and those with policy drafting and implementation experience in this area should be
included in future research projects. These expansive perspectives would provide rich insight
into the rationale and practice for positive policy adoption nationwide.
Another key consideration beyond the scope of this work is the additional barriers to
healthcare for TGNB people beyond plan coverage. Case studies, interviews, and surveys of
TGNB individuals who have received care or have been refused care would also be important
future research to capture the individual level and lived experiences of TGNB healthcare
impacts.
To inform public health advocates, policymakers, and program administrators seeking
to effect a more equitable Medicaid system for TGNB beneficiaries, we recommend a fourpronged approach. First, Medicaid programs should remove prior authorization requirements
wherever applicable. Inclusionary states should remove the need for prior authorization and
letters of medical necessity for non-genital/breast procedures. The SOC (2012) acknowledge
that “Although most of these procedures are generally labeled “purely aesthetic,” these same
operations in an individual with severe gender dysphoria can be considered medically
necessary, depending on the unique clinical situation of a given patient’s condition and life
situation” (p. 64). In other states, the removal of prior authorizations for surgeries and
hormone medications will remove many barriers to needed care.
Second, medical providers must be held to a high standard of TGNB competency.
One of the indicators we looked at when selecting states was the number of medical school
graduates each year within that state. In fact, the five inclusionary states in this analysis are
all among the seven highest in the country for this measure. In a system that relies upon
prior authorizations, physicians have an extraordinary amount of power. A comprehensive
TGNB health curriculum within medical school programs would be one way to properly
harness that power and build trust with TGNB patients. Testing for these competencies
through state licensing boards and offices of professions would be another. Incorporating
these competencies into the National Health Services Corps program, which offers
participating providers student loan forgiveness, would be yet another.
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Our third recommendation is for state Medicaid programs to establish specific review
boards for TGNB coverage determination cases. If the public administration literature is to
be taken seriously, these public servants would be well-situated for cultural competency
training. Like medical providers, these individuals should be trained in TGNB health. This
competency will assist them in making informed decisions and offering guidance to lessinformed providers. Whenever possible, this board should have at least one physician who is
well-versed in TGNB care provision standards.
The final recommendation is to improve leadership at the federal level. The Centers
for Medicare and Medicaid should make a national coverage determination for the treatment
of gender dysphoria and gender reassignment surgery. Had the Centers for Medicare and
Medicaid made such determination when it last had the opportunity in 2016, it is likely that
all states would have inclusive policies similar to those in California. Advocacy efforts led by
TGNB-serving organizations, physician groups, and public health officials will need to
convince CMS to reconsider their position that there is a lack of clinical evidence in support
of a national coverage determination. The WPATH - and its associated USPATH- could play
an important role.
Ultimately, transgender and non-binary indviduals in the current U.S. context should
be afforded equitable treatement in public health programs. TGNB medical needs are known,
the standards of care exist, and there is an established link between inclusive policies and
positive health outcomes; yet, pockets of erasure exist, resulting in coverage gaps for many.
As public administrators, those who construct and implement state Medicaid policy have an
obligation to promote the health of the entire population served, and TGNB health needs
should be no exception. In consideration of current federal TGNB policy, state Medicaid
administrators are uniquely positioned to enact policies that will reduce disparities and better
serve this population. To do so, they should adopt inclusive TGNB coverage policies that
recognize the medical necessity of the services standardized by the WPATH.
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